Bridgefront Capital’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-22,706
Closed -$111K 728
2024
Q2
$111K Buy
+22,706
New +$111K 0.05% 447